Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy

Donald E Cutlip, Dean J Kereiakes, Laura Mauri, Robert Stoler, Harold L Dauerman, EDUCATE Investigators, Donald E Cutlip, Dean J Kereiakes, Laura Mauri, Robert Stoler, Harold L Dauerman, EDUCATE Investigators

Abstract

Objectives: This study sought to assess the frequency and clinical impact of dual antiplatelet therapy (DAPT) nonadherence.

Background: There are limited data on the impact of DAPT nonadherence during the first year after a second-generation drug-eluting stent placement.

Methods: After successful Endeavor zotarolimus-eluting stent implantation, 2,265 patients were enrolled in a registry with limited exclusions and monitored during 12 months of prescribed DAPT. Predictors of any nonadherence (ANA) at 6 months were analyzed by multivariable analysis, and the association between ANA at 6 or 12 months with the endpoints of death, myocardial infarction, and stent thrombosis was assessed.

Results: The study population included 30% female patients, 34% with diabetes and 36% with acute coronary syndromes. ANA occurred in 208 patients (9.6%) before 6 months and 378 patients (18.5%) before 1 year. Major bleeding (odds ratio [OR]: 12.83, 95% confidence interval [CI]: 7.55 to 21.80, p < 0.001) was the only predictor of ANA at 6 months. In time-dependent analyses, ANA before 6 months was associated with an increased risk of death or myocardial infarction (7.6% vs. 3.0%, p < 0.001) and a numerical increase in stent thrombosis (2.0% vs. 0.9%, p = 0.12). After adjustment for baseline differences, ANA within 6 months remained associated with death or MI (OR: 1.95, 95% CI: 1.02 to 3.75). ANA occurring after 6 months did not increase the risk of subsequent ischemic events.

Conclusions: DAPT ANA occurs frequently and is associated with increased risk for thrombotic complications if it occurs within the first 6 months. Major bleeding was a significant correlate of DAPT ANA within 6 months. (EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events; NCT01069003).

Keywords: antiplatelet therapy; stent; thrombosis.

Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Source: PubMed

3
Prenumerera